Using ADLT™ to Facilitate Therapeutic Drug Development-Investor Perspective

October 4, 2016

iSolve

Press

Investors face multiple challenges in identifying the right portfolio company for their funds. Currently, only about 1/3^rd of investments return the 3.5-5x Cash on Cash returns expected of a successful VC firm. On the other side of the coin, companies have a difficult time connecting with the right investors and Investment Associates spend a lot of time talking to companies that are not good fits for their portfolio. Additionally, investors have self-imposed geographic limitations due to their belief they need to be physically close to their portfolio company, which has prevented building a truly balanced, global portfolio, of companies.